Abstract

The continuing development of nonlinear imaging, as well as a whole new generation of contrast agents, holds out great prospects in improving liver imaging. Optimization of the equipment settings for different classes of contrast agents is essential in the detection and characterization of focal liver lesions. On the basis of the preliminary results of multicenter clinical trials, it is reasonable to assume that their application in specific clinical settings will impact favorably on patient management.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call